P002 | GLIAL REMODELING DURING GLIOBLASTOMA PROGRESSION
European Journal of Histochemistry · 20.11.2026 · 70 (s2)
DOI: 10.4081/ejh.2026.4822 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Histochemistry, online erschienen am 20.11.2026. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Glioblastoma (GBM) is a highly aggressive brain tumor whose progression is shaped by dynamic interactions with the surrounding neuroglial microenvironment. However, how glial responses evolve during tumor progression remains incompletely understood. Here, we investigated neuroglial remodeling during GBM progression using mouse organotypic brain slice cultures, which preserve native tissue architecture and multicellular interactions. Acute brain slices, DPBS-treated, and GL261-implanted organotypic cultures were analyzed by confocal immunofluorescence and western blot. Slice viability was assessed by MTT assay and tumor cell proliferation by Ki-67 immunofluorescence. Glial remodeling was investigated by glial fibrillary acidic protein (GFAP) and ionized calcium-binding adapter molecule 1 (Iba1) immunofluorescence, including quantitative analysis of GFAP-positive area fraction and network architecture. Connexin 43 (Cx43), P2X4 receptor (P2X4R), and nuclear factor kappa B (NF-κB) were investigated as molecular components associated with connexin, purinergic, and inflammatory signaling. MTT assay showed preserved metabolic activity in DPBS-treated organotypic slices compared with acute tissue and significantly higher metabolic activity in GL261-implanted slices, while Ki-67-positive cells indicated active proliferation within the tumor tissue. GFAP immunofluorescence showed local signal enhancement and reactive-like astrocytic features at the tumor-tissue interface. However, quantitative analysis showed no global differences in GFAP-positive area fraction or network architecture among experimental conditions. Cx43/Actin was significantly lower in GBM 3-day slices than in acute tissue in the lysate fraction, while remaining higher than in DPBS-treated slices. These findings support a multifaceted remodeling of the glial microenvironment during GBM progression that may not be fully captured by global GFAP network metrics alone. Integrating spatial glial responses with molecular changes in connexins, purinergic, and inflammatory signaling may therefore provide a more comprehensive view of neuroglial remodeling within the GBM microenvironment.
Zitieren
APA
(2026). P002 | GLIAL REMODELING DURING GLIOBLASTOMA PROGRESSION. European Journal of Histochemistry, 70(s2). https://doi.org/10.4081/ejh.2026.4822
Vancouver
P002 | GLIAL REMODELING DURING GLIOBLASTOMA PROGRESSION. European Journal of Histochemistry. 2026;70(s2). doi:10.4081/ejh.2026.4822
BibTeX
@article{euvimed2026,
title = {P002 | GLIAL REMODELING DURING GLIOBLASTOMA PROGRESSION},
journal = {European Journal of Histochemistry},
year = {2026},
volume = {70},
number = {s2},
doi = {10.4081/ejh.2026.4822}
}
EUVIMED